FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157642973> ?p ?o ?g. }

• W3157642973 endingPage "17" @default.
• W3157642973 startingPage "12" @default.
• W3157642973 abstract "Background. The ongoing COVID-19 pandemic in the world and in Russia remains the main event in 2020. A comprehensive study of the patterns of development and manifestations of the epidemic process of the new coronavirus infection COVID-19 is an urgent line of research. One of the important aspects of the fight against COVID-19 is the study of population immunity to the SARS-CoV-2 virus in order to assess seroprevalence and the formation process of post-infectious humoral immunity to SARS-CoV-2, forecast the development of the epidemiological situation, identify the features of the epidemic process, as well as planning measures for specific and non-specific disease prevention. The aim of the research is to determine the level and structure of population immunity to SARS-CoV-2 among the humans of the Irkutsk region during the COVID-19 epidemic . Materials and methods. As part of the Rospotrebnadzor project to assess population immunity to SARS-CoV-2 in the population of the Russian Federation, research is being conducted among the population of the Irkutsk region in the periods from 06/23/2020 to 07/19/2020 (stage 1), from 09/16/2020 to 09/25/2020 (Stage 2) and from 12/07/2020 to 12/18/2020 (stage 3), taking into account the reacted one recommended by the WHO. The content of antibodies to SARS-CoV-2 was determined by ELISA using a set of tests for human serum or plasma for specific immunoglobulins of class G to the nucleocapsid of the SARS-CoV-2 virus produced by FBUN GNCPMiB Rospotrebnadzor (Obolensk). The results of a research of the humoral immunity of volunteers show that during the period of an epidemic rise in the incidence of COVID-19 in the Irkutsk region, a low level of seroprevalence was formed (stage 1 – 5.8 ± 0.5%, stage 2 – 12,1 ± 0,7%), and in conditions of a long-term maximum increase in the incidence rate ¬– 25,9±1,0% (stage 3). A significant proportion (stage 1 – 81,2±3,2%, stage 2 – 90.9 ±1,9%) of asymptomatic forms of infection characterize the high intensity of the latently developing epidemic process in the first two stages. High levels of IgG in reconvalescents of COVID-19 persisted for an average of 3 to 4.5 months. Conclusion. The results of assessing the population immunity to the SARS-CoV-2 virus in the population of the Irkutsk region indicate that the seroprevalence level at the 3rd stage of the research was 25.9%. After the disease, on average, 41.6% of persons did not detect antibodies. The results obtained should be taken into account when organizing preventive measures, including vaccination, and predicting morbidity." @default.
• W3157642973 created "2021-05-10" @default.
• W3157642973 creator A5015724820 @default.
• W3157642973 creator A5018210330 @default.
• W3157642973 creator A5020839529 @default.
• W3157642973 creator A5027207439 @default.
• W3157642973 creator A5039342418 @default.
• W3157642973 creator A5039901097 @default.
• W3157642973 creator A5042595790 @default.
• W3157642973 creator A5043812043 @default.
• W3157642973 creator A5069393128 @default.
• W3157642973 creator A5080525128 @default.
• W3157642973 creator A5077855094 @default.
• W3157642973 date "2021-05-03" @default.
• W3157642973 modified "2023-09-27" @default.
• W3157642973 title "Dynamics of changes in population immunity to the SARS-CоV-2 virus in residents the Irkutsk region in the context of the COVID-19 pandemic" @default.
• W3157642973 cites W2903899730 @default.
• W3157642973 cites W3001971765 @default.
• W3157642973 cites W3014022531 @default.
• W3157642973 cites W3016767494 @default.
• W3157642973 cites W3023609288 @default.
• W3157642973 cites W3026560496 @default.
• W3157642973 cites W3036647442 @default.
• W3157642973 cites W4205317059 @default.
• W3157642973 cites W4206651655 @default.
• W3157642973 cites W4236657475 @default.
• W3157642973 doi "https://doi.org/10.31631/2073-3046-2021-20-2-12-17" @default.
• W3157642973 hasPublicationYear "2021" @default.
• W3157642973 type Work @default.
• W3157642973 sameAs 3157642973 @default.
• W3157642973 citedByCount "8" @default.
• W3157642973 countsByYear W31576429732021 @default.
• W3157642973 countsByYear W31576429732022 @default.
• W3157642973 countsByYear W31576429732023 @default.
• W3157642973 crossrefType "journal-article" @default.
• W3157642973 hasAuthorship W3157642973A5015724820 @default.
• W3157642973 hasAuthorship W3157642973A5018210330 @default.
• W3157642973 hasAuthorship W3157642973A5020839529 @default.
• W3157642973 hasAuthorship W3157642973A5027207439 @default.
• W3157642973 hasAuthorship W3157642973A5039342418 @default.
• W3157642973 hasAuthorship W3157642973A5039901097 @default.
• W3157642973 hasAuthorship W3157642973A5042595790 @default.
• W3157642973 hasAuthorship W3157642973A5043812043 @default.
• W3157642973 hasAuthorship W3157642973A5069393128 @default.
• W3157642973 hasAuthorship W3157642973A5077855094 @default.
• W3157642973 hasAuthorship W3157642973A5080525128 @default.
• W3157642973 hasBestOaLocation W31576429731 @default.
• W3157642973 hasConcept C126322002 @default.
• W3157642973 hasConcept C151730666 @default.
• W3157642973 hasConcept C159047783 @default.
• W3157642973 hasConcept C159654299 @default.
• W3157642973 hasConcept C203014093 @default.
• W3157642973 hasConcept C2778494684 @default.
• W3157642973 hasConcept C2779134260 @default.
• W3157642973 hasConcept C2779341262 @default.
• W3157642973 hasConcept C2779343474 @default.
• W3157642973 hasConcept C2908647359 @default.
• W3157642973 hasConcept C3008058167 @default.
• W3157642973 hasConcept C45189115 @default.
• W3157642973 hasConcept C524204448 @default.
• W3157642973 hasConcept C71924100 @default.
• W3157642973 hasConcept C86803240 @default.
• W3157642973 hasConcept C8891405 @default.
• W3157642973 hasConcept C89623803 @default.
• W3157642973 hasConcept C99454951 @default.
• W3157642973 hasConceptScore W3157642973C126322002 @default.
• W3157642973 hasConceptScore W3157642973C151730666 @default.
• W3157642973 hasConceptScore W3157642973C159047783 @default.
• W3157642973 hasConceptScore W3157642973C159654299 @default.
• W3157642973 hasConceptScore W3157642973C203014093 @default.
• W3157642973 hasConceptScore W3157642973C2778494684 @default.
• W3157642973 hasConceptScore W3157642973C2779134260 @default.
• W3157642973 hasConceptScore W3157642973C2779341262 @default.
• W3157642973 hasConceptScore W3157642973C2779343474 @default.
• W3157642973 hasConceptScore W3157642973C2908647359 @default.
• W3157642973 hasConceptScore W3157642973C3008058167 @default.
• W3157642973 hasConceptScore W3157642973C45189115 @default.
• W3157642973 hasConceptScore W3157642973C524204448 @default.
• W3157642973 hasConceptScore W3157642973C71924100 @default.
• W3157642973 hasConceptScore W3157642973C86803240 @default.
• W3157642973 hasConceptScore W3157642973C8891405 @default.
• W3157642973 hasConceptScore W3157642973C89623803 @default.
• W3157642973 hasConceptScore W3157642973C99454951 @default.
• W3157642973 hasIssue "2" @default.
• W3157642973 hasLocation W31576429731 @default.
• W3157642973 hasOpenAccess W3157642973 @default.
• W3157642973 hasPrimaryLocation W31576429731 @default.
• W3157642973 hasRelatedWork W3048644831 @default.
• W3157642973 hasRelatedWork W3119540162 @default.
• W3157642973 hasRelatedWork W3152606407 @default.
• W3157642973 hasRelatedWork W3152916563 @default.
• W3157642973 hasRelatedWork W3169409437 @default.
• W3157642973 hasRelatedWork W3169715394 @default.
• W3157642973 hasRelatedWork W3214493312 @default.
• W3157642973 hasRelatedWork W4313474620 @default.
• W3157642973 hasRelatedWork W4327956415 @default.
• W3157642973 hasRelatedWork W4381942459 @default.
• W3157642973 hasVolume "20" @default.

• next